Fluorescence imaging can be conducted with long Stokes shift dyes that minimize crosstalk between the excitation source and fluorescent emission to improve the signal-to-background ratio. Regardless, ...

Working with concurrent electroencephalogram and functional magnetic resonance imaging technology at the Beckman Institute's ...

Autonomous micro- and nanomotors improve image clarity, targeting, and multimodal performance across advanced biomedical imaging systems. (Nanowerk News) Researchers are developing intelligent micro- ...

Artificial intelligence is being increasingly used to boost the performance of multimodal biomedical imaging. The capabilities of AI are helpful for the design of the imaging systems which capture ...

Researchers at Rochester Institute of Technology developed new artificial intelligence techniques to extract and visualize information from standard-of-care biomedical data, providing a means for ...

Two new open-source tools are set to make fluorescence lifetime imaging microscopy—or FLIM—faster, simpler and more accessible. Developed by Ph.D. student Sofia Kapsiani in Professor Gabi Kaminski ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

Biomedical Imaging and Cancer Engineering research revolves around the relentless pursuit of innovating and appraising novel imaging modalities and methodologies. This vast domain encompasses device ...

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.

Terahertz Imaging Detection Market Report 2026–2032: market size to reach US$951.95 million by 2032 at 13.79% CAGR.

InterMed, which is backed by Granite Bridge Partners, has acquired Modern Biomedical & Imaging Inc, a provider of healthcare technology management services. No financial terms were disclosed. New York ...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--On January 16, 2025, Neuraly Inc. (Neuraly), a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA, Inc. (Enigma) announced the signing of a ...